$60.01
-0.511 (-0.84%)
At Close: Jun 02, 2026
Reckitt Benckiser Bets on AI to Speed Innovation and Boost Growth
11:07pm, Thursday, 14'th May 2026
Reckitt Benckiser Group LON: RKT executives used an investor “Focus On” event to outline how the company is applying digital science, artificial intelligence and predictive modeling across its inn
Swiss bank sees upside for Reckitt Benckiser though the Dettol and Durex owner needs to "rebuild trust"
09:59am, Monday, 27'th Apr 2026
UBS sees nearly 60% total return potential in Reckitt Benckiser Group PLC (LSE:RKT, FRA:3RB, XETRA:3RB with the Swiss bank repeating a Buy rating and 7,400p price target. It comes after a meeting wi
Reckitt stock dips on Q1 miss: what's really ailing the health giant?
04:28am, Wednesday, 22'nd Apr 2026
Reckitt stock fell about 5% in early trading on Wednesday after the consumer goods group said first-quarter core like-for-like net revenue rose only 1.3%. The figure was well below the 2.9% analysts h
Reckitt's Like-for-Like Revenue Rises on Emerging Markets Performance
02:50am, Wednesday, 22'nd Apr 2026
Lysol maker Reckitt Benckiser booked a rise in first-quarter like for like revenue, helped by strong emerging markets performance, where like-for-like sales grew 7.6%.
Reckitt Benckiser Group plc (RBGLY) Presents at UBS Global Consumer and Retail Conference Transcript
05:22pm, Wednesday, 11'th Mar 2026
Reckitt Benckiser Group plc (RBGLY) Presents at UBS Global Consumer and Retail Conference Transcript
Reckitt not yet rewarded for improved earnings model, says UBS after strong quarter
07:51am, Friday, 06'th Mar 2026
UBS maintained its 'buy' rating on Reckitt Benckiser Group PLC (LSE:RKT, FRA:3RB, XETRA:3RB), the consumer goods company behind brands including Dettol, Nurofen and Durex, on Friday but cut its price
Reckitt Benckiser Group plc (RBGLY) Q4 2025 Earnings Call Transcript
06:32am, Thursday, 05'th Mar 2026
Reckitt Benckiser Group plc (RBGLY) Q4 2025 Earnings Call Transcript
Reckitt beats its own targets and signals confidence in 2026 after year of strategic progress
02:51am, Thursday, 05'th Mar 2026
Consumer health group delivers core growth ahead of medium-term guidance as emerging markets surge and Essential Home disposal completes Reckitt Benckiser Group PLC (LSE:RKT, FRA:3RB, XETRA:3RB), the
Lysol Maker Reckitt Books Rise in Revenue, Boosted by Emerging Markets
02:48am, Thursday, 05'th Mar 2026
The Lysol disinfectant maker's sales grew 5% on a like-for-like basis on year, Reckitt Benckiser said.
Reckitt Benckiser Group (OTCMKTS:RBGPF) Stock Price Down 0.3% – What’s Next?
02:26am, Thursday, 15'th Jan 2026
Reckitt Benckiser Group plc (OTCMKTS:RBGPF - Get Free Report)'s share price fell 0.3% during trading on Wednesday. The company traded as low as $81.3550 and last traded at $81.3550. 657 shares changed
Reckitt downgraded by RBC as Deutsche Bank strikes more bullish tone
06:47am, Wednesday, 14'th Jan 2026
Reckitt Benckiser Group PLC (LSE:RKT, XETRA:3RB) has received sharply contrasting verdicts from analysts, after RBC Capital Markets downgraded the shares while Deutsche Bank renewed its 'buy' rating,
Reckitt to pay £1.6bn special dividend after Essential Home sale
02:51am, Wednesday, 07'th Jan 2026
Reckitt Benckiser Group PLC (LSE:RKT, XETRA:3RB) has unveiled plans to hand back about £1.6 billion to shareholders through a one-off special dividend, following the sale of its Essential Home busine
Avatars, influencers in China livestreams help drive Reckitt's emerging-market led growth
08:12am, Friday, 05'th Dec 2025
Influencers and AI-generated avatars selling everything from Durex condoms to Harpic toilet cleaner on livestreaming apps in China are propelling emerging-market led growth for consumer goods company
Reckitt Benckiser Group Plc. ADR (RBGLY) Focus On Emerging Markets: Growth Opportunities and Strategic Capabilities Discussion Transcript
Reckitt steadies its course as bank lifts target
08:23am, Thursday, 23'rd Oct 2025
Reckitt Benckiser Group PLC's (LSE:RKT, ETR:3RB) turnaround may finally be gaining traction. RBC Capital Markets has raised its price target from £60 to £64 and reiterated an outperform rating, argu
Sign In
Buy RBGPF